To explore the role of PRDM4 in the development and progression of cervical cancer, we examined the mRNA levels of PRDM4 in 304 patients with cervical cancer and found that it was significantly lower than that in 13 patients without malignant tumors in The Cancer Genome Atlas (TCGA) RNA-Seq database (Fig. 1A, p < 0.05). This evidence concerns the gene PRDM4 and cancer.